prostate-report.org

Early prostate cancer may not always benefit from treatment with hormones

A new research findings appear to essentially change the risk-benefit profile when doctors will decide which treatment suits which patient. The study conclusion suggests that men who have been diagnosed with prostate cancer and who also have underlying heart disease may not benefit from treatment with hormones.

Several clinical trials have shown that hormone therapy, when used with radiation therapy, can increase survival in men who have more aggressive cancer But this benefit tended to shrink in men who also suffered from other conditions. This new results would suggest that if they do have preexisting heart disease that either hormone therapy not be used or that their underlying heart disease be initially addressed by their primary care physician and/or a cardiologist.